| 标题 |
专利、报告等 poster presented at ASCO 2025. Abstract 8639
海报在ASCO 2025上展示。摘要8639
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | Amivantamab plus chemotherapy vs chemotherapy in EGFR-mutant advanced NSCLC after disease progression on osimertinib: Outcomes by osimertinib resistance mechanisms in MARIPOSA-2 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)